| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.9 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |